08:19 AM EDT, 10/03/2024 (MT Newswires) -- Legend Biotech ( LEGN ) said Thursday it is constructing a new research and development site in Philadelphia, Pennsylvania for advancing its cell therapies portfolio.
The company anticipates to complete the development in Q3 2025.
The new facility is expected to have 55 full-time employees, the company said.
Price: 48.41, Change: -0.27, Percent Change: -0.55